X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32821) 32821
Publication (4676) 4676
Book Review (206) 206
Newsletter (86) 86
Book Chapter (77) 77
Newspaper Article (46) 46
Conference Proceeding (26) 26
Dissertation (13) 13
Magazine Article (11) 11
Book / eBook (7) 7
Data Set (4) 4
Reference (3) 3
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
reverse transcriptase polymerase chain reaction (21879) 21879
humans (21371) 21371
index medicus (16655) 16655
animals (15162) 15162
male (11991) 11991
female (10597) 10597
mice (7817) 7817
blotting, western (7262) 7262
adult (5724) 5724
gene expression (5557) 5557
expression (5402) 5402
rna, messenger - genetics (4978) 4978
middle aged (4874) 4874
cells, cultured (4706) 4706
oncology (4623) 4623
rats (4482) 4482
immunohistochemistry (4124) 4124
immunology (3979) 3979
rna, messenger - metabolism (3680) 3680
research (3559) 3559
analysis (3536) 3536
cell biology (3516) 3516
apoptosis (3332) 3332
biochemistry & molecular biology (3296) 3296
pharmacology & pharmacy (3206) 3206
hiv infections - drug therapy (3086) 3086
cancer (2986) 2986
proteins (2944) 2944
cell line, tumor (2835) 2835
infectious diseases (2768) 2768
aged (2716) 2716
research article (2700) 2700
gene-expression (2696) 2696
flow cytometry (2685) 2685
virology (2587) 2587
cells (2536) 2536
cell line (2478) 2478
hiv (2440) 2440
genetic aspects (2397) 2397
mice, inbred c57bl (2391) 2391
health aspects (2372) 2372
activation (2361) 2361
article (2351) 2351
physiological aspects (2311) 2311
base sequence (2234) 2234
medicine (2208) 2208
real-time polymerase chain reaction (2207) 2207
gene expression profiling (2169) 2169
hematology (2166) 2166
reverse transcriptase inhibitors - therapeutic use (2164) 2164
in-vitro (2140) 2140
rna (2133) 2133
enzyme-linked immunosorbent assay (2116) 2116
time factors (2054) 2054
polymerase chain reaction (2024) 2024
mutation (1976) 1976
inflammation (1968) 1968
multidisciplinary sciences (1960) 1960
molecular sequence data (1936) 1936
signal transduction (1877) 1877
neurosciences (1875) 1875
oligonucleotide array sequence analysis (1850) 1850
cell proliferation (1847) 1847
rats, sprague-dawley (1787) 1787
endocrinology & metabolism (1769) 1769
science (1744) 1744
reverse transcriptase polymerase chain reaction - methods (1680) 1680
genes (1672) 1672
anti-hiv agents - therapeutic use (1659) 1659
hiv infections - virology (1658) 1658
rna, messenger - analysis (1610) 1610
in-vivo (1592) 1592
microbiology (1589) 1589
tumor cells, cultured (1582) 1582
dose-response relationship, drug (1579) 1579
hiv-1 - drug effects (1579) 1579
up-regulation (1564) 1564
physiology (1550) 1550
rodents (1548) 1548
biology (1543) 1543
medicine, research & experimental (1535) 1535
dna primers (1476) 1476
disease models, animal (1456) 1456
infection (1456) 1456
messenger rna (1445) 1445
mice, knockout (1434) 1434
messenger-rna (1414) 1414
cytokines (1412) 1412
rna, messenger - biosynthesis (1407) 1407
phosphorylation (1404) 1404
pathology (1395) 1395
gene (1385) 1385
care and treatment (1356) 1356
differentiation (1350) 1350
gene expression regulation (1326) 1326
angiogenesis (1321) 1321
antiviral agents (1321) 1321
therapy (1321) 1321
apoptosis - drug effects (1308) 1308
adolescent (1298) 1298
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32856) 32856
Chinese (48) 48
Spanish (37) 37
French (25) 25
German (12) 12
Japanese (9) 9
Russian (9) 9
Polish (7) 7
Italian (5) 5
Korean (5) 5
Turkish (3) 3
Dutch (2) 2
Danish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 4/2008, Volume 61, Issue 4, pp. 914 - 918
Journal Article
Journal of Chromatography B, ISSN 1570-0232, 2008, Volume 867, Issue 2, pp. 205 - 212
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 06/2017, Volume 56, Issue 6, pp. 661 - 669
Introduction Doravirine, a non-nucleoside reverse-transcriptase inhibitor in development for the treatment of patients with human immunodeficiency virus-1... 
REVERSE-TRANSCRIPTASE INHIBITOR | THERAPY | ONCE-DAILY DOLUTEGRAVIR | RALTEGRAVIR | SAFETY | RESISTANCE | PHARMACOLOGY & PHARMACY | HIV-1 INFECTION | INTEGRASE INHIBITOR DOLUTEGRAVIR | ANTIRETROVIRAL-NAIVE ADULTS | RITONAVIR | HIV Integrase Inhibitors - pharmacology | Triazoles - adverse effects | Triazoles - blood | Reverse Transcriptase Inhibitors - blood | Area Under Curve | Heterocyclic Compounds, 3-Ring - pharmacology | Humans | Reverse Transcriptase Inhibitors - pharmacology | Male | Pyridones - blood | Reverse Transcriptase Inhibitors - adverse effects | Young Adult | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Adult | Female | Triazoles - pharmacokinetics | Fasting - metabolism | Drug Therapy, Combination | Heterocyclic Compounds, 3-Ring - pharmacokinetics | Pyridones - pharmacokinetics | HIV Integrase Inhibitors - pharmacokinetics | Triazoles - pharmacology | HIV Integrase Inhibitors - adverse effects | Heterocyclic Compounds, 3-Ring - blood | Heterocyclic Compounds, 3-Ring - adverse effects | HIV Integrase Inhibitors - blood | Pyridones - adverse effects | Pyridones - pharmacology | Highly active antiretroviral therapy | Care and treatment | Usage | Steady state theory | Research | Pharmacokinetics | HIV (Viruses) | Antiretroviral drugs | Chemotherapy | Protease inhibitors | Human immunodeficiency virus--HIV | Antimicrobial agents | Infections | FDA approval | Drug therapy | Patients | Drug dosages
Journal Article
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 02/2006, Volume 61, Issue 2, pp. 148 - 154
Journal Article
AIDS, ISSN 0269-9370, 09/2007, Volume 21, Issue 14, pp. 1899 - 1907
Objectives: To describe first dose and steady state antiretroviral drug exposure in the female genital tract. Design: Non-blinded, single center, open-label... 
Women | Genital tract | HIV | Prophylaxis | Sexual transmission | Pharmacokinetics | Antiretroviral therapy | genital tract | INFECTIOUS DISEASES | sexual transmission | antiretroviral therapy | EMTRICITABINE | IMMUNOLOGY | CEREBROSPINAL-FLUID | prophylaxis | BACTERIAL VAGINOSIS | PROTEASE INHIBITOR | TRICHOMONAS-VAGINALIS | HIV-INFECTION | THERAPY | VIROLOGY | LIQUID-CHROMATOGRAPHY | SIMIAN IMMUNODEFICIENCY VIRUS | pharmacokinetics | MACAQUES | women | Lamivudine - administration & dosage | Humans | Deoxycytidine - blood | Zidovudine - administration & dosage | Tenofovir | Deoxycytidine - pharmacokinetics | HIV Protease Inhibitors - pharmacokinetics | Atazanavir Sulfate | Genitalia, Female - metabolism | Emtricitabine | HIV Infections - blood | HIV Protease Inhibitors - blood | Adenine - analogs & derivatives | Pyridines - administration & dosage | Benzoxazines - administration & dosage | Administration, Oral | Anti-Retroviral Agents - pharmacokinetics | Deoxycytidine - administration & dosage | Lopinavir | HIV Protease Inhibitors - administration & dosage | Adenine - pharmacokinetics | Pyrimidinones - blood | Anti-Retroviral Agents - administration & dosage | Oligopeptides - administration & dosage | Pyrimidinones - administration & dosage | Zidovudine - blood | Deoxycytidine - analogs & derivatives | Reverse Transcriptase Inhibitors - blood | Zidovudine - pharmacokinetics | Pyridines - pharmacokinetics | Reverse Transcriptase Inhibitors - administration & dosage | Adenine - blood | Reverse Transcriptase Inhibitors - pharmacokinetics | Benzoxazines - pharmacokinetics | Adult | Benzoxazines - blood | Female | Organophosphonates - blood | Anti-Retroviral Agents - blood | Drug Therapy, Combination | Oligopeptides - blood | Oligopeptides - pharmacokinetics | Lamivudine - blood | Lamivudine - pharmacokinetics | Adenine - administration & dosage | Organophosphonates - pharmacokinetics | Organophosphonates - administration & dosage | Pyridines - blood | Pyrimidinones - pharmacokinetics | HIV Infections - drug therapy
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 01/2016, Volume 44, Issue 1, pp. 151 - 161
Efavirenz (EFV) is principally metabolized by CYP2B6 to 8-hydroxy-efavirenz (8OH-EFV) and to a lesser extent by CYP2A6 to 7-hydroxy-efavirenz (7OH-EFV). So... 
400 MG | TRIAL | THERAPY | CYP2B6 | HIV | MORPHINE | LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY | MORPHINE-6-GLUCURONIDE | PHARMACOLOGY & PHARMACY | ACTIVE-TRANSPORT | BLOOD-BRAIN-BARRIER | Neurotoxicity Syndromes - genetics | Reverse Transcriptase Inhibitors - blood | Humans | Anti-HIV Agents - cerebrospinal fluid | Glucuronides - cerebrospinal fluid | Cytochrome P-450 CYP2B6 - metabolism | Glucuronides - blood | Reverse Transcriptase Inhibitors - adverse effects | Tandem Mass Spectrometry | Reverse Transcriptase Inhibitors - pharmacokinetics | Benzoxazines - urine | Cytochrome P-450 CYP3A - genetics | Benzoxazines - pharmacokinetics | Sulfates - blood | HIV Infections - diagnosis | Benzoxazines - blood | Anti-HIV Agents - blood | Reverse Transcriptase Inhibitors - urine | Metabolic Detoxication, Phase II | Hydroxylation | Risk Assessment | Cytochrome P-450 CYP2A6 - genetics | Cytochrome P-450 CYP2B6 - genetics | Anti-HIV Agents - adverse effects | Benzoxazines - cerebrospinal fluid | Benzoxazines - adverse effects | Cytochrome P-450 CYP2A6 - metabolism | Genotype | Glucuronides - urine | Anti-HIV Agents - urine | Reverse Transcriptase Inhibitors - cerebrospinal fluid | Sulfates - cerebrospinal fluid | Metabolomics - methods | Neurotoxicity Syndromes - etiology | Phenotype | Sulfates - urine | Cytochrome P-450 CYP3A - metabolism | Anti-HIV Agents - pharmacokinetics | Metabolic Detoxication, Phase I | Neurotoxicity Syndromes - metabolism | HIV Infections - drug therapy | HIV Infections - metabolism | Index Medicus
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2012, Volume 7, Issue 7, p. e40382
Antiviral pre-exposure prophylaxis (PrEP) through daily drug administration can protect healthy individuals from HIV-1 infection. While PrEP was recently... 
VIRAL DYNAMICS | POPULATION PHARMACOKINETICS | POSTEXPOSURE PROPHYLAXIS | ACTIVE ANTIRETROVIRAL THERAPY | DISOPROXIL FUMARATE | IN-VIVO | BIOLOGY | CD4(+) T-CELLS | STEADY-STATE | HEALTHY-VOLUNTEERS | SIMULATION-MODEL | HIV Infections - prevention & control | Reverse Transcriptase Inhibitors - blood | Humans | Reverse Transcriptase Inhibitors - pharmacology | Adenine - blood | Dose-Response Relationship, Drug | Tenofovir | Reverse Transcriptase Inhibitors - pharmacokinetics | Adenine - therapeutic use | Organophosphonates - blood | Reverse Transcriptase Inhibitors - therapeutic use | HIV Infections - blood | Adenine - analogs & derivatives | Intracellular Space - drug effects | Organophosphonates - therapeutic use | Administration, Oral | HIV-1 - drug effects | HIV Infections - virology | Treatment Outcome | Adenine - pharmacology | Adenine - pharmacokinetics | Organophosphonates - pharmacokinetics | Organophosphonates - pharmacology | Models, Biological | Intracellular Space - metabolism | HIV Infections - drug therapy | Kinetics | Viral Load - drug effects | Prevention | DNA polymerases | Dosage and administration | HIV (Viruses) | Drug therapy | Drug approval | Health aspects | Phosphorylation | RNA-directed DNA polymerase | Prophylaxis | Clinical trials | Viruses | Infections | Mathematics | Hepatitis | Human immunodeficiency virus--HIV | Mathematical models | Drug dosages | Deoxyribonucleic acid--DNA | Antiretroviral drugs | Antiviral agents | Pills | Pharmacodynamics | Sensitivity analysis | Effectiveness | Data processing | Radioactive half-life | Pharmacology | Exposure | Computer science | Disease transmission | Stochasticity | Pharmacokinetics | Deoxyribonucleic acid | HIV | DNA | Human immunodeficiency virus
Journal Article